Furthermore, circCDYL (hsa_circ_0008285) was reported to augment autophagy of breast cancer cells via regulating the miR-1275-ATG7/ULK1 axis, which may be a potential biomarker for predicting the prognosis of breast cancer patients [218]. The gene discussed is ULK1; the disease is breast carcinoma.